INTERNATIONAL PATENT: AVIDENCE THERAPEUTICS, INC. FILES APPLICATION FOR "MICROSPHERE-BASED INJECTABLE ROFECOXIB FORMULATION"

GENEVA, Oct. 6 -- AVIDENCE THERAPEUTICS, INC. (423 West 127th StreetNew York, New York 10027) filed a patent application (PCT/US2025/020665) for "MICROSPHERE-BASED INJECTABLE ROFECOXIB FORMULATION" on Mar 20, 2025. With publication no. WO/2025/207396, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Ang (363 West 123rd Street, Apt. 1RNew York, New York 10027)

Abstract: This invention provides a biodegradable microsphere, wherein the microsphere (i) has a diameter of from 1 Mum to 500 Mum; (ii) comprises a polylactic-c...